DPAP
DPAP is a p-ERK1/2 inhibitor with an IC50 of 7.85 μM against p-ERK1/2. DPAP inhibits the expression of p-MEK1/2 and disrupts the Ras-ERK signaling pathway. DPAP inhibits the expression of COX-2 in nerve cells. DPAP damages DNA and mitochondria, induces Apoptosis via the mitochondrial pathway, and upregulates PD-L1. DPAP inhibits melanoma metastasis and angiogenesis, and inactivates spinal microglia and astrocytes. DPAP exhibits anti-melanoma activity and can be combined with anti-PD-1 monoclonal antibodies to modify anti-tumor effects. DPAP is applicable for the research of melanoma.
For research use only. We do not sell to patients.
- Formula: C22H28Cl2N2O10Pt
- Molecular Weight:746.46
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
COX-2 |
In Vitro
The cellular uptake of DPAP (2 μM; 72 h) in A375 melanoma cells is 2.53-fold higher than that of CDDP[1].
DPAP (72 h) inhibits the proliferation of melanoma A375 cells, mouse melanoma B16-F10 cells, and normal renal HK-2 cells. After 72 h of incubation, its IC50 values are 8.05 μM, 5.96 μM, and 35.12 μM, respectively, indicating selective cytotoxicity against cancer cells[1].
DPAP (1-8 μM; 72 h) increases the level of DNA-bound Pt in A375 melanoma cells; at 8 μM for 72 h, it upregulates the expression of γ-H2AX, indicating the presence of DNA damage[1].
DPAP (8 μM; 48 h) induces S-phase cell cycle arrest in melanoma A375 cells[1].
DPAP (8 μM; 72 h) regulates the expression of apoptosis-related proteins (upregulating Cyt c and Bax, downregulating Bcl-2) and induces late apoptosis in human melanoma A375 cells[1].
DPAP (8 μM; 72 h) regulates the Ras-ERK signaling pathway in melanoma A375 cells[1].
DPAP (8 μM; 24 h) downregulates the expressions of p-ERK1/2 and COX-2, but does not alter the expression of NF-L, in HT22 mouse hippocampal neuronal cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:A375 cells
-
Concentration:8 μM
-
Incubation Time:48 h
-
Result:Arrested A375 cells primarily in the S phase, similar to CDDP, indicating inhibition of DNA synthesis.
-
Cell Line:A375 cells
-
Concentration:8 μM
-
Incubation Time:72 h
-
Result:Significantly downregulated p-MEK1/2 and p-ERK1/2 expression relative to control cells, while having only slight effects on NRAS, MEK1/2, and ERK1/2 expression.
-
Cell Line:HT22 cells
-
Concentration:8 μM
-
Incubation Time:24 h
-
Result:Suppressed p-ERK1/2 and COX-2 expression in HT22 cells relative to control cells, and did not affect NF-L expression, unlike CDDP which reduced NF-L levels.
In Vivo
DPAP (1.5 mg Pt kg−1; intravenous injection; once every 2 days; for 1 week) inhibits the activation of microglia and astrocytes in the spinal dorsal horn of melanoma-bearing mice, demonstrating potential to alleviate cancer pain-related central sensitization[1].
Combination treatment with DPAP (2.5 mg Pt kg-1; intravenous injection; once every 2 days; for 2 consecutive weeks) and anti-PD-1 mAb (12.5 mg kg-1; intravenous injection; administered on days 4, 9 and 14) synergistically enhances the anti-melanoma efficacy[1].
DPAP (10-40 mg kg-1; intravenous injection; once every 2 days) exhibits a high median lethal dose of 33.60 mg kg-1 and favorable biocompatibility in healthy female C57BL/6 mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (female, 6−8 weeks old, 18−20 g, subcutaneous inoculation of murine B16−F10 melanoma cells, tumors grown to ~50 mm3)[1]
-
Dosage:1.5 mg Pt kg-1
-
Administration:i.v.; once every 2 days; 15 days
-
Result:Reduced average tumor weight to 0.10 g, compared to 1.19 g in the PBS control group.
Reduced average tumor volume to 412.11 mm3, compared to 1539.47 mm3 in the PBS control group.
Caused no significant change in mouse body weight relative to the PBS group.
Showed no apparent alterations in heart, liver, spleen, lung, and kidney tissues via histological examination.
Significantly reduced the fluorescence intensity of p-ERK1/2 in tumor tissue.
Significantly weakened the fluorescence intensity of VEGF-A in tumor tissue.
Chemical Information
-
Molecular Weight 746.46
-
Formula C22H28Cl2N2O10Pt
-
SMILES
COC1=CC(OCC(O[Pt](Cl)(Cl)(OC(COC2=C(C(C)=O)C=CC(OC)=C2)=O)([NH3])[NH3])=O)=C(C(C)=O)C=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Phagocytosis Functional Assay
A phagocytosis functional assay measures the ability of phagocytic cells, such as neutrophils, macrophages, monocytes, or microglia/macrophages, to bind and internalize particulate targets including bacteria, yeast particles, beads, or myelin particles. Fluorescent flow-cytometry assays detect target uptake as fluorescence associated with gated phagocytes, while pH-sensitive dyes such as pHrodo increase signal in acidic phagosomal compartments and therefore preferentially report internalized particles rather than particles remaining outside the cell. Microscopy or high-content imaging can be used to confirm intracellular localization and, in some protocols, to follow uptake kinetics.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Detection of Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Human pluripotent stem cell endothelial-cell differentiation
Human pluripotent stem cell endothelial differentiation is based on stepwise developmental patterning: early activation of WNT/GSK3β inhibition promotes mesodermal or vascular progenitor entry, followed by endothelial specification using VEGF-related signaling, BMP4, FGF2, Notch modulation, or cAMP depending on the published protocol. Endothelial differentiation is read out by acquisition of CD31, CD34, VE-cadherin/CD144, KDR/VEGFR2, vWF, Tie2, NOS3, acetylated LDL uptake, tube/network formation, barrier function, and in vivo vessel-forming capacity where tested.
-
Vascular/Branching Fractal Analysis
Vascular/branching fractal analysis quantifies the geometric complexity of vessel trees or vascular networks from segmented 2D images, commonly by converting vessels into binary and/or skeletonized maps and estimating fractal dimension using box-counting or related approaches. Fractal dimension is interpreted as an image-derived readout of vascular branching complexity, space filling, or density, and has been applied to retinal photographs, fluorescein angiography, OCT angiography, capillary perfusion maps, and in vitro Matrigel angiogenesis networks. The assay readout is generated from vessel-positive pixels after image preprocessing, vessel segmentation, binarization, and optional skeletonization; reported outputs include fractal dimension, vessel density, branchpoint density, endpoint density, vessel length density, tortuosity, and generation-based branching metrics when VESGEN-style analysis is used. The biological interpretation is limited to quantitative vascular patterning and s
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Endothelial Tube Formation Assay
Endothelial tube formation assay evaluates the ability of endothelial cells to attach, migrate, align, and organize into capillary-like networks when cultured on gelled basement membrane extract or Matrigel; the readout is the morphology and quantity of tube-like networks, which reflects an in vitro endothelial morphogenesis step related to angiogenesis. Basement membrane extract/Matrigel provides laminin-rich extracellular matrix cues that support endothelial differentiation into capillary-like structures, but it can contain biologically active growth factors, so growth-factor-reduced matrix is preferred when testing defined angiogenic stimulators or inhibitors.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Orthotopic Cell-Line Xenograft
Orthotopic cell-line xenograft models involve implantation of human cancer cell lines into the anatomically corresponding organ of immunodeficient mice to reproduce tumor growth within a native microenvironment, enabling more clinically relevant tumor behavior compared with subcutaneous models. These models are widely used because orthotopic placement better recapitulates tumor progression, including invasion and metastatic spread, which are often underrepresented in heterotopic implantation systems. Compared with conventional xenografts, orthotopic implantation is described as more technically complex but provides improved simulation of tumor-microenvironment interactions and metastatic behavior, making it particularly valuable for translational oncology research. Surgical orthotopic implantation approaches have been emphasized as enabling faithful reproduction of clinical cancer features, including metastasis and disease progression patterns that align with the tumor’s organ of origi
-
Endothelial Cell Migration/Angiogenic Sprouting Assay
Endothelial cell migration and angiogenic sprouting assays are in vitro (and partially ex vivo-adapted) functional models that quantify the ability of endothelial cells to undergo coordinated migration, extracellular matrix invasion, and multicellular organization into capillary-like sprouts in response to pro-angiogenic stimuli such as VEGF, bFGF, or conditioned microenvironments. These assays are used to model early angiogenic events including tip-cell formation, directional migration, and lumen-like sprout extension, which collectively reflect angiogenic activation and vascular morphogenesis processes observed in vivo.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)